PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
01-Nov-2022 Catalent, Inc. Reports First Quarter Fiscal 2023 Results Businesswire
01-Nov-2022 Waters Corporation (NYSE: WAT) Reports Third Quarter 2022 Financial Results Businesswire
01-Nov-2022 PFIZER REPORTS STRONG THIRD-QUARTER 2022 RESULTS AND RAISES 2022 OUTLOOK Businesswire
01-Nov-2022 China Pharmaceutical Contract Manufacturing Market Report 2022: Increasing Prevalence of Non-Communicable Diseases Drives Growth - ResearchAndMarkets.com Businesswire
01-Nov-2022 QHP Capital Forms Continuation Vehicle for Catalyst Clinical Research Businesswire
01-Nov-2022 Henry Schein Reports Record Non-GAAP Third-Quarter 2022 Diluted EPS Financial Results Businesswire
01-Nov-2022 Johnson & Johnson to Acquire Abiomed Businesswire
01-Nov-2022 Global Mass Flow Controller Market Report 2022: Demand from Fast-Growing Pharmaceutical Industry Driving Growth - ResearchAndMarkets.com Businesswire
01-Nov-2022 Biopreservation Market Report 2022: Growing R&D Spending on Medication Equipment Boosts Sector - ResearchAndMarkets.com Businesswire
01-Nov-2022 Global Viral Vector Production Market Report 2022: Technological Breakthroughs in Vector Manufacturing and a Reliable Pipeline for Gene Treatments and Viral Vector Vaccinations Drives Growth - ResearchAndMarkets.com Businesswire
01-Nov-2022 United Therapeutics Corporation to Present at the Credit Suisse 31st Annual Healthcare Conference Businesswire
01-Nov-2022 Acclaimed Life Sciences Leaders Launch Impact Investment Firm to Accelerate Health Equity Businesswire
01-Nov-2022 Global Recombinant Proteins Market Report 2022: Increased R&D Spending by Pharmaceutical Companies Boosting Growth - ResearchAndMarkets.com Businesswire
01-Nov-2022 Bio-Thera Solutions Initiates Phase III Clinical Trial for BAT2306, a Proposed Biosimilar of Cosentyx® (Secukinumab) Businesswire
01-Nov-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
01-Nov-2022 Memo Therapeutics AG and Ono Pharmaceutical Enter Antibody Discovery Partnership for Immuno-oncology Targets Businesswire
01-Nov-2022 Tetris Pharma Launches Ogluo® in Germany Businesswire
01-Nov-2022 Eucure Biopharma, a Subsidiary of Biocytogen, Announces Partnership with ISU ABXIS for the Development of Tri-specific Antibodies using YH003 Antibody Sequence Businesswire
01-Nov-2022 Eucure Biopharma, a Subsidiary of Biocytogen, Announces Partnership with ISU ABXIS for the Development of Tri-specific Antibodies using YH003 Antibody Sequence Businesswire
28-Oct-2022 Pro-ficiency Launches New Solution: Pro-Active Protocol Newswire